Sale!

PRKN Gene PARK2 Parkinson Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The PRKN Gene (PARK2) Parkinson Genetic Test is a specialized diagnostic procedure designed to identify mutations in the PARK2 gene, which is closely associated with the development of Parkinson’s disease. This test is crucial for individuals who have a family history of Parkinson’s disease or exhibit early symptoms, as it can provide vital information regarding their risk of developing the condition.

Performed at DNA Labs UAE, a leading facility in genetic testing, the test involves collecting a DNA sample, usually through a blood draw or cheek swab, and analyzing it for specific genetic alterations in the PARK2 gene. These mutations are known to cause the early onset of Parkinson’s disease by affecting the function of the protein parkin, which plays a significant role in the degradation of unwanted proteins in brain cells.

The cost of the PRKN Gene (PARK2) Parkinson Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the sophisticated technology and expertise required to accurately identify mutations in the PARK2 gene. For individuals at risk, this test provides invaluable insights into their genetic predisposition to Parkinson’s disease, enabling them to make informed decisions about their health and future.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

PRKN Gene PARK2 Parkinson Genetic Test Price 4400 AED

At DNA Labs UAE, we offer the PRKN Gene PARK2 Parkinson Genetic Test. This test is designed to detect mutations in the PRKN gene, which is associated with Parkinson’s disease. Parkinson’s disease is a neurological disorder characterized by the degeneration of dopamine-producing neurons in the brain.

Test Details

The PRKN gene, also known as PARK2, is one of the genes associated with Parkinson’s disease. Mutations in this gene are a known cause of early-onset Parkinson’s disease. Our test uses NGS (Next-Generation Sequencing) technology to analyze multiple genes simultaneously, including the PRKN gene.

Components

  • Test Name: PRKN Gene PARK2 Parkinson Genetic Test
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Before undergoing the PRKN Gene PARK2 Parkinson NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by PRKN Gene PARK2 Parkinson.

Benefits of the Test

An NGS genetic test can identify specific genetic variants that may increase the risk of developing Parkinson’s disease or confirm a diagnosis in individuals with suspected genetic forms of the disease. This information can be valuable for both diagnostic and predictive purposes, helping individuals and their healthcare providers make informed decisions about treatment options and disease management.

Ordering and Interpretation

NGS genetic tests for Parkinson’s disease should be ordered and interpreted by qualified healthcare professionals. It is recommended to seek genetic counseling before and after testing to ensure a thorough understanding of the implications of the results and to receive support and guidance.

Test NamePRKN Gene PARK2 Parkinson Genetic Test
Components
Price 4400.0 AED
Sample ConditionBlood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery3 to 4 Weeks
MethodNGS Technology
Test typeNeurological Disorders
DoctorNeurologist
Test Department:Genetics
Pre Test InformationClinical History of Patient who is going for PRKN Gene PARK2 Parkinson NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with PRKN Gene PARK2 Parkinson
Test DetailsThe PRKN gene, also known as PARK2, is one of the genes associated with Parkinson’s disease. Mutations in this gene are a known cause of early-onset Parkinson’s disease.

NGS (Next-Generation Sequencing) genetic tests are a type of genetic testing that uses high-throughput sequencing technologies to analyze multiple genes simultaneously. In the context of Parkinson’s disease, an NGS genetic test can be used to detect mutations in the PRKN gene, as well as other genes associated with the condition.

By analyzing the DNA of an individual, NGS genetic tests can identify specific genetic variants that may increase the risk of developing Parkinson’s disease or confirm a diagnosis in individuals with suspected genetic forms of the disease. This information can be valuable for both diagnostic and predictive purposes, helping individuals and their healthcare providers make informed decisions about treatment options and disease management.

It is important to note that NGS genetic tests for Parkinson’s disease are typically performed in specialized laboratories and should be ordered and interpreted by qualified healthcare professionals. Genetic counseling is often recommended before and after testing to ensure individuals understand the implications of the results and to provide support and guidance.